Dermal Fillers in Korea — LENA, Juvederm & Belotero Near Incheon Airport

Hyaluronic Acid Fillers: Biocompatibility and Volumization

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in all human connective tissue, with the highest concentrations in skin, joints, and vitreous humor. The skin alone contains approximately 50% of the body’s total HA, making it the primary molecule responsible for dermal hydration and volume. HA-based fillers like Juvederm use VYCROSS cross-linking technology to create cohesive gels that resist degradation while maintaining natural tissue integration. LENA filler from L&C Bio uses advanced cross-linking to provide stable volumization at an accessible price point. When injected into the dermis or subcutaneous tissue, HA filler immediately attracts and binds water molecules — each HA molecule can hold up to 1,000 times its weight in water — providing instant volumization and hydration that integrates seamlessly with surrounding tissue.

A meta-analysis by Rohrich et al. (2019) analyzing 52 randomized controlled trials involving over 6,000 patients demonstrated that HA-based fillers achieved statistically significant improvement in wrinkle severity scores across all treatment areas, with satisfaction rates exceeding 90% at 6-month follow-up. The safety profile was excellent, with serious adverse events occurring in less than 0.3% of cases — and the availability of hyaluronidase as a reversal agent provides an additional safety net unique to HA fillers. This extensive safety data applies equally to LENA, Juvederm, and Belotero fillers used at RE:BERRY Incheon Airport.

Rohrich RJ, et al. Hyaluronic acid fillers: a comprehensive review of the literature. Plast Reconstr Surg. 2019;143(4):1141-1153. doi:10.1097/PRS.0000000000005489

Filler Placement in the Nasolabial Fold: Anatomical Precision

The nasolabial fold — the crease running from each side of the nose to the corners of the mouth — is one of the most commonly treated areas with dermal fillers worldwide. Its formation involves a complex interplay of malar fat pad descent, maxillary bone resorption, and dermal thinning. Carruthers et al. (2007) published in the Journal of Cosmetic and Laser Therapy that optimal nasolabial fold correction requires multi-layer injection: a deep bolus at the supraperiosteal level to lift the overlying soft tissue, followed by superficial serial puncture or retrograde linear threading to smooth the skin surface. This technique, standard at RE:BERRY Incheon Airport, produces results lasting 8-18 months depending on filler type. LENA filler at ₩149,000 provides effective nasolabial correction at an exceptional value point.

Carruthers JD, Glogau RG, Blitzer A. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies. J Cosmet Laser Ther. 2007;9(sup1):S29-S35. doi:10.1080/14764170701280544

Chin and Jawline Augmentation: The Korean V-Line Approach

Non-surgical chin augmentation with dermal fillers has become one of the fastest-growing aesthetic procedures globally, and Korea leads innovation in this area. Park et al. (2020) published in the Aesthetic Surgery Journal that combining chin filler with masseteric botulinum toxin (the approach offered at RE:BERRY as the Juvederm Chin + Botox package at ₩390,000) produces synergistic V-line results superior to either treatment alone. The filler provides direct chin projection and definition, while the Botox reduces masseter muscle bulk over 4-6 weeks, narrowing the lower face. The combination creates a more defined, proportional facial profile. Korean physicians have refined this dual-treatment approach through high-volume practice — Dr. Cho at RE:BERRY Incheon Airport performs this combination treatment regularly on international patients seeking the coveted Korean V-line.

Park TH, et al. Chin augmentation with hyaluronic acid filler: evaluation of current techniques and outcomes. Aesthet Surg J. 2020;40(9):NP472-NP480. doi:10.1093/asj/sjaa091